Brent Ogilvie, Managing Director, is a co-founder and shareholder in the company. Mr Ogilvie provides extensive life sciences commercial experience and an invaluable network of colleagues in international affiliates in the ag-biotech market, especially in North America, Europe and North Asia, including proven deal making ability with several of the world’s largest AI companies. Pacific Channel and the principals of its US affiliate, The Channel Group, LLC have several decades of experience in the life sciences market, including the management and eventual sale of the world’s largest manufacturer of bovine serum albumin.
Jim Mervis, Chairman and independent director, specialises in company development in life sciences and communications. He has an extensive background in securities and commercial transactions; defining and establishing strategic alliances and securing the financial and human resources for corporate growth.
Dr Gary Pace is an investor director with a successful serial career as a biotech entrepreneur who is a director of multiple ASX listed and US listed companies.
Dr Cather Simpson is the lead inventor of the technology andone of New Zealand’s most highly regarded scientists. Cather has a joint appointment in the Department of Physics and the School of Chemical Sciences at the University of Auckland. She is the Director of the Photon Factory and a Principal Investigator in two of New Zealand’s Centres of Research Excellence. She has expertise in photochemistry and photophysics, ultrafast laser micromachining, and device R&D. As a director of the Photon Factory, Cather manages micro to nano-fabrication facilities that can machine microscopic features in virtually any material.
Kieran Jina, Operations Manager, provides operational and IP support, and market insights to Engender. He holds degrees in Master of Science (Hons) in Biomedical Science and a Master of Bioscience Enterprise (Hons) from the University of Auckland. Kieran has experience in assessing market opportunities, technical review, assessment of technology development plans, analysis of competing technologies and review of market potential and commercialization strategies. Kieran assists other early stage biotechnology companies through his role at Pacific Channel. Kieran previous was the Market Analyst at Aroa Biosurgery.
Peter Hosking, Head Engineer and Project Manager, graduated with a BE (Hons) degree in Mechatronics Engineering from the University of Auckland in 2010. Peter was appointed as Head Engineer of the Photon Factory, a role with technical and management responsibilities for research for academic, Crown Research Institute, and industry facing projects. Since 2012 Peter has driven the sorting, imaging and fluorescence detection components of Engender’s technology. He is responsible for system integration and software management, and helps guide the microfluidic and photonic chip design.